
Gynecology
Latest News
Latest Videos

Shorts










More News

The incidence of SUI at 6 weeks post partum was 8.7% for the PEFLOW group compared to 13.9% for those receiving usual care (P = .03).

ACOG now recommends a combination of transvaginal ultrasonography and endometrial tissue sampling for the initial evaluation of most patients presenting with postmenopausal bleeding.

According to ACOG, approximately 90% of patients diagnosed with endometrial cancer have postmenopausal bleeding. Read more on the College's updated recommendations below.

Moving LiSWT into formal postpartum care guidelines will require randomized controlled trials with adequate sample sizes, defined treatment parameters, long-term follow-up, and dedicated safety data in lactating patients, with cost-effectiveness analysis also identified as a priority research direction.

Scott Sullivan, MD, highlights that a third of Virginia is a maternity desert, creating even more severe gaps for patients requiring maternal-fetal medicine.

The FDA cleared the Onclarity HPV Self-Collection Kit, allowing patients to collect samples at home for processing via the FDA-cleared BD Onclarity HPV Assay and BD COR System.

LiSWT may offer a noninvasive option for postpartum pelvic pain, with potential benefits across both chronic and earlier-stage scar-related dysfunction.

PinkDx announced an IJGC publication of data that demonstrated signals associated with endometrial cancer can be detected from a vaginal swab.

Simon highlights the "seamless handoff" between FQHCs and OB hospitalists as a vital mechanism for maintaining delivery access in rural and underserved communities.

Get caught up with Contemporary OB/GYN! This list helps you navigate our top stories from the week, all in one place.

Livi is a single-use, soft polyurethane foam device cleared by the FDA to absorb semen and vaginal discharge within approximately 60 seconds.

Get caught up with Contemporary OB/GYN! This list helps you navigate our top stories from the week, all in one place.

Among a survey of over 800 providers, menopause care was the top area for expected greatest improvement over the next 5 years.

Among 2029 women in Scandinavian countries who were followed up for 14 years, vaccine effectiveness was 100%.

A case report describes the first known use of low-intensity extracorporeal shock wave therapy for episiotomy scar pain, with a patient reporting meaningful improvement after more than 20 years of chronic pelvic floor dysfunction.


Sara Perelmuter advocates for routine postpartum screening and provider education on lactation-safe therapies when dealing with GSL symptoms.

Clinicians are advised to discuss reproductive risks and fertility preservation options with all cancer patients prior to initiating therapy to maximize future reproductive potential.

Sara Perelmuter details how naming Genitourinary Syndrome of Lactation (GSL) is a vital step in addressing the treatment gap in postpartum care.

According to FLO Living, the Cycle Syncing Method resulted in 92% of participants reporting meaningful reductions in the number and intensity of PMS symptoms after 60 days.

Alessandro Santin, MD, highlights how POLE and mismatch repair mutations in high-grade ESS create a clinical opportunity for using immune checkpoint inhibitors.

"It's only when you acquire the type of deep knowledge in the molecular characteristic that you may really identify potential targets," said study investigator Alessandro Santin, MD.

The Menopause Society reported new data from 68 health organizations that showed vaginal estrogen therapy does not elevate recurrence risk in survivors aged 18 to 51.

Researchers reported that lidocaine did not affect POUR rates but enhanced early recovery metrics after SUI surgery.

An institution-wide policy allowing elective induction at 39 weeks was linked to lower cesarean delivery and NICU admission rates.















